Unknown

Dataset Information

0

Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets.


ABSTRACT: The lack of functional understanding of most mutations in cancer, combined with the non-druggability of most proteins, challenge genomics-based identification of oncology drug targets. We implemented a machine-learning-based approach (idTRAX), which relates cell-based screening of small-molecule compounds to their kinase inhibition data, to directly identify effective and readily druggable targets. We applied idTRAX to triple-negative breast cancer cell lines and efficiently identified cancer-selective targets. For example, we found that inhibiting AKT selectively kills MFM-223 and CAL148 cells, while inhibiting FGFR2 only kills MFM-223. Since the effects of catalytically inhibiting a protein can diverge from those of reducing its levels, targets identified by idTRAX frequently differ from those identified through gene knockout/knockdown methods. This is critical if the purpose is to identify targets specifically for small-molecule drug development, whereby idTRAX may produce fewer false-positives. The rapid nature of the approach suggests that it may be applicable in personalizing therapy.

SUBMITTER: Gautam P 

PROVIDER: S-EPMC6642004 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets.

Gautam Prson P   Jaiswal Alok A   Aittokallio Tero T   Al-Ali Hassan H   Wennerberg Krister K  

Cell chemical biology 20190502 7


The lack of functional understanding of most mutations in cancer, combined with the non-druggability of most proteins, challenge genomics-based identification of oncology drug targets. We implemented a machine-learning-based approach (idTRAX), which relates cell-based screening of small-molecule compounds to their kinase inhibition data, to directly identify effective and readily druggable targets. We applied idTRAX to triple-negative breast cancer cell lines and efficiently identified cancer-se  ...[more]

Similar Datasets

| S-EPMC6912926 | biostudies-literature
| S-EPMC8008812 | biostudies-literature
| S-EPMC7739401 | biostudies-literature
2013-01-01 | E-GEOD-29210 | biostudies-arrayexpress
| S-EPMC9912626 | biostudies-literature
| S-EPMC5872818 | biostudies-literature
| S-EPMC3660065 | biostudies-literature
| S-EPMC4937748 | biostudies-literature
| S-EPMC7691515 | biostudies-literature
| S-EPMC6428806 | biostudies-literature